ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 884,26
0,08%
DAX
18 430,05
1,42%
Brent Oil
82,685
-0,22%
Bitcoin
62 777,59
0,73%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) Actualités

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateHeureSourceTitreSymboleSociété
07/05/202411h45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersNASDAQ:AVXLAnavex Life Sciences Corporation
06/05/202412h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVXLAnavex Life Sciences Corporation
03/05/202411h45PR Newswire (US)Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/05/202413h30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
26/04/202411h45PR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
19/04/202411h45PR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
16/04/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
12/04/202411h45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
11/04/202413h30GlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
05/04/202411h45PR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/04/202411h45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
29/03/202410h45PR Newswire (US)Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
26/03/202410h45PR Newswire (US)Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
25/03/202412h30GlobeNewswire Inc.Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
22/03/202410h45PR Newswire (US)AVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:AVXLAnavex Life Sciences Corporation
18/03/202412h30GlobeNewswire Inc.Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
26/02/202413h30GlobeNewswire Inc.Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202412h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
07/02/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
07/02/202413h30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
01/02/202413h30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
25/01/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVXLAnavex Life Sciences Corporation
24/01/202413h30GlobeNewswire Inc.Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in HumansNASDAQ:AVXLAnavex Life Sciences Corporation
16/01/202413h30GlobeNewswire Inc.Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
08/01/202413h30GlobeNewswire Inc.Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental DisordersNASDAQ:AVXLAnavex Life Sciences Corporation
03/01/202413h30GlobeNewswire Inc.Anavex to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
02/01/202414h00GlobeNewswire Inc.Anavex Life Sciences Provides an Update on Rett Syndrome ProgramNASDAQ:AVXLAnavex Life Sciences Corporation
20/12/202313h30GlobeNewswire Inc.Anavex Announces First Entire Clinical Gene Pathway Data of ANAVEX®2-73 from AVATAR Study in Patients with Rett SyndromeNASDAQ:AVXLAnavex Life Sciences Corporation
19/12/202313h30GlobeNewswire Inc.Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer’s DiseaseNASDAQ:AVXLAnavex Life Sciences Corporation
27/11/202322h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL

Dernières Valeurs Consultées

EU
ORA
Orange
EU
ACA
Credit Agricole
NYSE
NKE
Nike
EU
DG
Vinci
EU
PX4
SBF 120
EU
PX1
CAC 40
EU
GLE
Societe Generale
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
EU
LR
Legrand
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés